Autoantibodies against type I IFNs in patients with life-threatening COVID-19 - Bastard, Paul; Rosen, Lindsey B.; Zhang, Qian; Michailidis, Eleftherios; Hoffmann, Hans-Heinrich; Zhang, Yu; Dorgham, Karim; Philippot, Quentin; Rosain, Jérémie; Béziat, Vivien; Manry, Jérémy; Shaw, Elana; et al. (Science (American Association for the Advancement of Science), 2020)
Keywords: Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Neutralizing - blood; Antiviral drugs; Asymptomatic; Asymptomatic Infections; Autoantibodies; Autoantibodies - blood; Autoimmunity; Betacoronavirus; Case-Control Studies; Control Groups; Coronaviridae; Coronavirus Infections; Coronavirus Infections - immunology; Coronaviruses; COVID-19; Critical Illness; Cytokines; Disease; Female; Genetics; Humans; Immune system; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulins; Immunology; Infections; Infectious diseases; Interferon alpha-2; Interferon alpha-2 - immunology; Interferon Type I; Interferon Type I - immunology; Life Sciences; Male; Males; Middle Aged; Mutation; Online; Pandemics; Patients; Pneumonia; Pneumonia, Viral; Pneumonia, Viral - immunology; Public health; Respiratory diseases; Risk factors; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Viral infections